Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, Wash. and NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutic...

Early report Major update Updated Mar 6, 2026, 9:05 PM UTC

Track this event Edit in app More event pages

What changed

Another report from GlobeNewswire Public Companies sharpened the story 4h ago.

First seen Mar 6, 2026, 1:00 PM UTC Latest source Mar 6, 2026, 9:05 PM UTC

Update 1 4h ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Public Companies •published Mar 6, 2026, 9:05 PM UTC •fetched Mar 6, 2026, 9:11 PM UTC

Update 2 12h ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Public Companies •published Mar 6, 2026, 1:00 PM UTC •fetched Mar 6, 2026, 1:15 PM UTC